Health Care companies develop and sell a wide variety of products and services.  The majority of Health Care companies in the Canadian industry are focused on drug products, including ones that are for hospital use only, prescription and non-prescription products; medical devices and diagnostics are also important sub-sectors.  Research coverage will assess companies that supply solutions to unmet medical and market needs and will include a balanced mix of companies with approved products, revenues and growth, as well as others that are developing products with large market potential with approaching critical milestones.

Research analyst specializing in environmental/industrial/transportation:

Wayne Schnarr, Ph.D.

(416) 864-2065

wschnarr@blackmont.com

Wayne brings with him tremendous experience accumulated over a 30-year career in the Canadian Health Care sector.  On three separate occasions, Wayne served as a health care analyst at various investment dealers, most recently at Canaccord Capital (2000-2001).  He has also served in senior executive roles for Canadian public health care companies including VP Corporate Development at Oncolytics Biotech (2001-2003).  His experience also entails more than 10 years in pharmaceutical manufacturing in Canada.  In his latest role, Wayne served as Senior VP Life Sciences for the Equicom Group (2003-2008) where he directed a team overseeing investor relations services for more than 40 Canadian health care clients.